Unique Exercise Lactate Profile in Muscle Phosphofructokinase Deficiency (Tarui Disease); Difference Compared with McArdle Disease
Päivi Piirilä(Helsinki University Hospital), Mari Auranen(University of Helsinki), Tomi Wuorimaa(Institute for Molecular Medicine Finland), Lasse Uotila(Helsinki University Hospital), Petri Haapalahti(University of Helsinki), Johanna Palmio, Henna Tyynismaa(University of Helsinki), Bjarne Udd(Folkhälsans Forskningscentrum), Minna E. Similä(Helsinki University Hospital), Satu Sandell(Seinäjoki University of Applied Sciences), Emil Ylikallio(University of Helsinki)
Cited by 11
Related Papers
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
|The Lancet Neurology|2012|487
Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin
|The American Journal of Human Genetics|2002|484
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study
|The Lancet Neurology|2011|420
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
|EMBO Molecular Medicine|2014|386